Minoryx Therapeutics and Neuraxpharm Group have announced a significant breakthrough in the treatment of cerebral adrenoleukodystrophy (cALD) in paediatric...
Read MoreBayer has officially begun a Phase 1 clinical trial for BAY3498264, an investigational oral selective SOS1 inhibitor designed to...
Read MoreDudley-based pork pie maker T.C. Morris has taken a significant step forward in its journey, securing a five-figure funding...
Read MoreEverest Medicines has announced groundbreaking results from its Phase 1b/2a clinical trial of EVER001, a novel Bruton’s tyrosine kinase...
Read MoreBranston, one of the UK’s leading potato suppliers, is gearing up to launch an exciting new brand, Nanna Tate,...
Read MoreTeva Pharmaceutical Industries has unveiled encouraging results from its Phase 3 SPACE study, highlighting the efficacy and safety of...
Read More